Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Computational Structural Analysis Predicts Host-Range Promiscuity and Antiviral Resistance in North American H5N1 Lineages.

Computational and structural biotechnology journal·2026
Same author

Using Apple Watches to Monitor Health and Behaviors of Individuals With Cognitive Impairment: A Case Series Study.

The journals of gerontology. Series A, Biological sciences and medical sciences·2024
Same author

Behavioral and transcriptomic analyses of mecp2 function in zebrafish.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2024
Same author

Genetic capitalism and stabilizing selection of antimicrobial resistance genotypes in Escherichia coli.

Cladistics : the international journal of the Willi Hennig Society·2021
Same author

Whole genome sequencing of Plasmodium vivax isolates reveals frequent sequence and structural polymorphisms in erythrocyte binding genes.

PLoS neglected tropical diseases·2020
Same author

Assessment of predicted enzymatic activity of α-N-acetylglucosaminidase variants of unknown significance for CAGI 2016.

Human mutation·2019

相关实验视频

Updated: Jun 14, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

254

使用人工智能蛋白质扩散发现PD-1向抗体

Colby T Ford1,2,3,4

  • 1Tuple LLC, Charlotte, NC, USA.

Technology in cancer research & treatment
|September 4, 2024
PubMed
概括

研究人员通过计算设计了针对癌症的新型抗PD-1抗体片段. 这些合成Fv结构在瘤学中显示出有希望的结合性能,用于进一步测试针对编程细胞死亡蛋白1 (PD-1).

关键词:
在PD-1中使用PD-1.抗体是对抗体的重要组成部分.人工智能的人工智能是人工智能.瘤学 在瘤学方面.蛋白质的扩散蛋白质的扩散.

更多相关视频

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.2K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.8K

相关实验视频

Last Updated: Jun 14, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

254
Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.2K
Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.8K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 计算生物学 计算生物学

背景情况:

  • 编程细胞死亡蛋白1 (PD-1) 是一种关键的免疫检查点蛋白,可以抑制T细胞对癌症的反应.
  • 阻止PD-1增强了免疫系统清除瘤细胞的能力,使其成为瘤学的关键治疗标.
  • 现有的抗PD-1疗法,如尼沃卢马布和潘布罗利祖马布已经显示出成功,但需要新的治疗方法.

研究的目的:

  • 使用计算方法发现新的抗PD-1抗体碎片.
  • 通过in silico管道评估这些计算衍生碎片的结合潜力.

主要方法:

  • 利用蛋白质扩散用于抗体碎片的计算衍生.
  • 采用可扩展的in silico管道来评估预测的结合性能.
  • 生成了针对PD-1的合成Fv结构.

主要成果:

  • 通过计算成功地获得了多个抗PD-1抗体碎片.
  • 确定了9个合成Fv结构,具有理想的预测结合性能.
  • 这些结构适合对抗PD-1活性进行实证测试.

结论:

  • 计算式蛋白质设计可以有效地产生针对免疫检查点的新型抗体片段.
  • 提出的合成Fv结构代表了开发新的抗PD-1免疫疗法的有希望的候选人.
  • 需要进一步的经验验证,以确认这些新片段的治疗潜力.